# A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease

> **NCT06810960** · — · RECRUITING · sponsor: **Eisai Korea Inc.** · enrollment: 3000 (estimated)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT06810960
- **Lead sponsor:** Eisai Korea Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-24
- **Primary completion:** 2029-09-30
- **Final completion:** 2029-09-30
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06810960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06810960, "A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT06810960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*